ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRISYU........*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/01727809CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120081029W184deBibliographieenBibliographyfrBibliographieEP05706819.9200503092006101220061227enenen20040041220040312DK552574 P20040312US2008102920084420061206200649200806112008242007112320081029200844C07D 295/12 20060101AFI20050927BHEP C07D 265/06 20060101ALI20050927BHEP C07D 279/12 20060101ALI20050927BHEP C07D 417/04 20060101ALI20050927BHEP A61K 31/4406 20060101ALI20050927BHEP A61K 31/541 20060101ALI20050927BHEP A61K 31/5355 20060101ALI20050927BHEP A61P 25/22 20060101ALI20050927BHEP deSUBSTITUIERTE MORPHOLIN- UND THIOMORPHOLINDERIVATEenSUBSTITUTED MORPHOLINE AND THIOMORPHOLINE DERIVATIVESfrDERIVÉS DE MORPHOLINE ET DE THIOMORPHOLINE SUBSTITUÉSWO-A-02/49628WO-A-02/066036US-A1- 2001 049 444MAIN M J ET AL: "MODULATION OF KCNQ2/3 POTASSIUM CHANNELS BY THE NOVEL ANTICONVULSANT RETIGABINE" MOLECULAR PHARMACOLOGY, BALTIMORE, MD, US, vol. 58, no. 2, August 2000 (2000-08), pages 253-262, XP000972245 ISSN: 0026-895XDATABASE BEILSTEIN BEILSTEIN CROSSFIRE INSTITUT ZUR FOERDERUNG DER CHEMISCHEN WISSENSCHAFTEN, DE; BRN 6233316 1993, XP002330358 & VERMA M AL: ARCH PHARM (WEINHEIM W GER), vol. 315, no. 7, 1982, pages 358-363,08007169.9194709320080411WENZEL TORNØE, ChristianSverrigsgade 20, 2 th.DK-2300 Copenhagen SDKROTTLÄNDER, MarioSvanemosen 10DK-2670 GreveDKKHANZHIN, NikolayTeglgårdsvej 545, 2 TVDK-3050 HumlebaekDKRITZÉN, AndreasHyltebjerg Alle 48V, 3.tvDK-2720 VanløseDKWATSON, William PatrickJyllingevej 81 st.DK-2720 VanløseDKH. Lundbeck A/S02852420489-ep-eptOttiliavej 92500 Valby-CopenhagenDKATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEISITLILTLUMCNLPLPTROSESISKTRAL20061012BA20061012HR20061012LV20061012MK20061012YU20061012DK200500015920050309enWO20050877542005092220053820061206200649